Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPV-16/18 AS04 Vaccine Phase III China Study
CTR20140383Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human papillomavirus type 16 L1 capsid protein antigen in human papillomavirus infection, cervical intraepithelial neoplasia (CIN), sponsored by GSK. Started Jul 2014; status: completed.
02
Drugs
human papillomavirus type 16 L1 capsid protein antigen
03
Conditions
human papillomavirus infectioncervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on CTR20140383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140383.